Somatostatin Receptor Type 4 (SSTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Somatostatin Receptor Type 4 (SSTR4) pipeline drugs market research report outlays comprehensive information on the Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hormonal Disorders, Central Nervous System, Metabolic Disorders, and Oncology which include indications of Acromegaly, Diabetic Neuropathic Pain, Low Back Pain, Neuroendocrine Tumors, Osteoarthritis Pain, Pain, and Pituitary ACTH Hypersecretion (Cushing Disease). It also reviews key players involved in Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics development with respective active and dormant or discontinued projects.
SSTR4 Pipeline Drugs Market by Key Therapy Areas
The key therapy areas of the SSTR4 pipeline drugs market are hormonal disorders, central nervous system, metabolic disorders, and oncology.
SSTR4 Pipeline Drugs Market, by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanism of Actions in the SSTR4 Pipeline Drugs Market
The key mechanism of action in the SSTR4 pipeline drugs market is Somatostatin Receptor Type 4 Agonist.
Key Routes of Administration in the SSTR4 Pipeline Drugs Market
The key routes of administration in the SSTR4 pipeline drugs market are subcutaneous and oral.
SSTR4 Pipeline Drugs Market, by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the SSTR4 Pipeline Drugs Market
The key molecule types in the SSTR4 pipeline drugs market are synthetic peptide, monoclonal antibody conjugated, and small molecule.
SSTR4 Pipeline Drugs Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the SSTR4 Pipeline Drugs Market
The key companies in the SSTR4 pipeline drugs market are Eli Lilly and Co, GlyTech Inc, Peptide Logic LLC, and Strongbridge Biopharma plc.
SSTR4 Pipeline Drugs Market, by Companies
To know more about the companies, download a free report sample
SSTR4 Pipeline Drugs Market Report Overview
Key Therapy Areas | Hormonal Disorders, Central Nervous System, Metabolic Disorders, and Oncology |
Key Mechanism of Actions | Somatostatin Receptor Type 4 Agonist |
Key Routes of Administration | Subcutaneous and Oral |
Key Molecule Types | Synthetic Peptide, Monoclonal Antibody Conjugated, and Small Molecule |
Key Companies | Eli Lilly and Co, GlyTech Inc, Peptide Logic LLC, and Strongbridge Biopharma plc |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Somatostatin Receptor Type 4 (SSTR4).
- Reviews of targeted therapeutics for Somatostatin Receptor Type 4 (SSTR4) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Somatostatin Receptor Type 4 (SSTR4) therapeutics and enlists all their major and minor projects.
- Assessment of Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type.
- Summarization of all the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics.
Reasons to Buy
- Gain strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Somatostatin Receptor Type 4 (SSTR4).
- Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding the Somatostatin Receptor Type 4 (SSTR4) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the SSTR4 pipeline drugs market?
The key therapy areas of the SSTR4 pipeline drugs market are hormonal disorders, central nervous system, metabolic disorders, and oncology.
-
What are the key mechanism of actions of the SSTR4 pipeline drugs market?
The mechanism of action of the SSTR4 pipeline drugs market is Somatostatin Receptor Type 4 Agonist.
-
What are the key routes of administration in the SSTR4 pipeline drugs market?
The key routes of administration in the SSTR4 pipeline drugs market are subcutaneous and oral.
-
What are the key molecule types in the SSTR4 pipeline drugs market?
The key molecule types in the SSTR4 pipeline drugs market are synthetic peptide, monoclonal antibody conjugated, and small molecule.
-
Which are the key companies in the SSTR4 pipeline drugs market?
The key companies in the SSTR4 pipeline drugs market are Eli Lilly and Co, GlyTech Inc, Peptide Logic LLC, and Strongbridge Biopharma plc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.